Concept Companies Breaks Ground on New Location for Lacerta Therapeutics in Alachua’s Copeland Park

Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company.

Oct. 9, 2019 10:00 UTC

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company. The 12,950 square foot building is expected to be completed in the Spring of 2020.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191009005226/en/

Strategically located in the heart of the North Florida Research Corridor in Alachua, Florida, Copeland Park offers state-of-the-art, build-to-suit laboratory and office space for biotechnology and life science companies. “Copeland Park is the perfect location for companies like Lacerta that are rapidly expanding and need new and flexible lab space,” said Brian Crawford, founder, owner and CEO of Concept Companies.

Joe Reddy, president and CEO of Lacerta Therapeutics, said: ''We are excited about our new office and lab space. This new facility will enable us to rapidly advance development of our broad pipeline of AAV gene therapy product candidates in multiple therapeutic areas. We have an option to expand into the adjoining parcel, which would enable us to leverage our proprietary, scalable AAV manufacturing platform.’'

Reddy added, “We look forward to working with Brian and his team at Concept Companies to build the space we need to achieve our goal of bringing life-saving gene therapy treatments to patients.”

About Lacerta Therapeutics

Lacerta Therapeutics is a clinical-stage gene therapy company that is leveraging its proprietary adeno-associated virus (AAV) vector technology and manufacturing platforms to develop treatments for central nervous system and lysosomal storage diseases. Currently, Lacerta is focused on gene therapy solutions for Pompe Disease, Sanfilippo Syndrome Type B, Neurodegenerative Proteinopathies, Spinocerebellar Ataxias and Glioblastoma. For more information visit www.lacertatherapeutics.com.

About Concept Companies

Concept Companies is a full-service real estate development and construction firm, headquartered in Gainesville, FL. Our services include commercial development, site selection through complete site construction, architectural and title insurance. We have a broad portfolio of successful projects in a variety of industries including retail, education, life sciences, fitness, hospitality, automotive and industrial construction. For more information visit conceptcompanies.net.

Contacts

Concept Companies Contact:
Emily Williams
Marketing Manager
352-333-3233, ext. 138
Emily@conceptcompanies.net

Lacerta Therapeutics Contact:
Joseph D. Reddy, Ph.D.
President & CEO
386-518-6142
joe@lacertatherapeutics.com

Media Contact:
Sandra Oak
Nsight Public Relations
321-591-1508
soak@nsightpr.com

Source: Concept Companies

Smart Multimedia Gallery

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20191009005226/en

MORE ON THIS TOPIC